Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	12 Months Ended		84 Months Ended
	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2012
Cash flows from operating activities:
Net loss	$ (1,249,491)	$ (1,495,607)	$ (17,602,280)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	35,925	14,492	176,373
Gain on extinguishment of debt	(288,192)		(288,192)
Amortization of costs and fees related to convertible debentures	356,487	183,904	1,160,234
Common stock issued for services		42,750	2,144,790
Common stock issued to officers, directors and consultants for services	132,796	59,385	3,211,491
Common stock issued for shares of subsidiary stock			254,000
Common stock of subsidiary issued to employees and consultants			2,815
Common stock issued as a commission			3,000
Common stock issued for accounts payable		18,000	296,583
Common stock issued to former licensee			41,319
Common stock issued/recovered on cancelled agreements			20,478
Non-cash compensation for stock options and warrants		29	631,923
Costs and fees related to issuance of convertible debt	3,288	2,139	542,540
Interest expense related to beneficial conversion feature			1,944,800
Interest paid with common stock		13,651	118,487
Interest on notes receivable for common stock			(1,373)
(Increase) decrease in assets:
Related party receivables	(15,269)		(15,269)
Prepaid expenses	(30,900)	86,648	(5,529)
Inventories	(25,600)	15,116	(101,388)
Increase (decrease) in liabilities:
Derivate liability	(175,865)	175,865
Trade accounts payable	(131,650)	137,746	484,894
Accounts payable to officers and directors	92,541	182,385	752,623
Accrued payroll and other expenses	172,332	99,274	433,649
Net cash used in operating activities	(1,123,598)	(464,223)	(5,794,032)
Cash flows from investing activities:
Purchase of fixed assets	(79,789)		(217,143)
Net cash used in investing activities	(79,789)		(217,143)
Cash flows from financing activities:
Principal payments on notes payable to stockholder	(140,500)		(1,273,500)
Proceeds from issuance of notes payable to a related party	80,000	34,000	1,119,800
Proceeds from issuance of notes and convertible notes payable	75,000	339,869	1,604,234
Proceeds from issuance of common stock	1,273,813	103,436	3,455,475
Net cash provided by financing activities	1,288,313	477,305	4,906,009
Net change in cash	84,926	13,082	(1,105,166)
Cash at beginning of period	5,206	(7,876)	1,195,298
Cash at end of period	90,132	5,206	90,132
Supplemental Disclosure of Cash Flow Information
Interest paid		664	10,985
Income taxes paid	1,600	1,600	20,240
Supplemental Schedule of Non-Cash Investing and Financing Activities
Conversion of convertible notes payable to shares of common stock	395,000	372,365
Notes converted by stockholders	315,500
Common stock issued in consideration for accounts payable and accrued payroll	680,804
Interest paid with common stock	127,982	13,651
Common stock issued in consideration for loans	3,288	2,139
Reclassification of inventory to fixed assets		$ 75,788